SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-003348
Filing Date
2021-03-23
Accepted
2021-03-23 08:31:03
Documents
86
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ettx-20201231x10k.htm   iXBRL 10-K 2074199
2 EX-21.1 ettx-20201231xex21d1.htm EX-21.1 6221
3 EX-23.1 ettx-20201231xex23d1.htm EX-23.1 3354
4 EX-31.1 ettx-20201231xex31d1.htm EX-31.1 8762
5 EX-31.2 ettx-20201231xex31d2.htm EX-31.2 10194
6 EX-32.1 ettx-20201231xex32d1.htm EX-32.1 8183
7 GRAPHIC ettx-20201231x10k001.jpg GRAPHIC 48390
8 GRAPHIC ettx-20201231x10k003.jpg GRAPHIC 16263
9 GRAPHIC ettx-20201231x10k004.jpg GRAPHIC 48427
10 GRAPHIC ettx-20201231x10k005.jpg GRAPHIC 34297
11 GRAPHIC ettx-20201231x10k006.jpg GRAPHIC 22177
  Complete submission text file 0001558370-21-003348.txt   8260342

Data Files

Seq Description Document Type Size
12 EX-101.SCH ettx-20201231.xsd EX-101.SCH 58688
13 EX-101.CAL ettx-20201231_cal.xml EX-101.CAL 60202
14 EX-101.DEF ettx-20201231_def.xml EX-101.DEF 193721
15 EX-101.LAB ettx-20201231_lab.xml EX-101.LAB 528641
16 EX-101.PRE ettx-20201231_pre.xml EX-101.PRE 392252
17 EXTRACTED XBRL INSTANCE DOCUMENT ettx-20201231x10k_htm.xml XML 1202486
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38670 | Film No.: 21763229
SIC: 2834 Pharmaceutical Preparations